- Title
- Public Health - Opioid Overdose Reversal Drugs - Standing Orders
- Sponsored by
- Senator Klausmeier
- Status
- In the Senate - Hearing 2/20 at 1:00 p.m.
- Analysis
- Fiscal and Policy Note
Synopsis
Requiring a licensed health care provider, when issuing a standing order for an opioid reversal drug, to allow an individual to choose any formulation of any opioid reversal drug approved by the federal Food and Drug Administration.
Committees
- Original:
- Finance Click to view Recorded Media
Details
History
Toggle History Dropdown
File Code
Toggle Filecode Dropdown
Subjects
Toggle Subjects Dropdown
Statutes
Toggle Statutes Dropdown
Last Updated: 2/21/2024 11:15 AM